Are you curious about the AOD 9604 peptide for your research needs? You’ve come to the right place. This guide covers AOD 9604 Peptide: Dosage, Benefits, and Side Effects.
Also, AOD 9604 peptide benefits for obesity-related complications and skeletal health will be discussed in this article. Find this peptide at NuScience Peptide, which has been an established source for over two decades.
Let’s understand the domain of AOD 9604 together.
Part 1. Understanding AOD 9604 Peptide
The term “AOD” stands for “Anti-obesity Drug”, as it was initially made for treating obesity.
It is a growth hormone-derived peptide that is composed of the C-terminal fragment of the human growth hormone. It specifically contains amino acids from 177–191, with an additional tyrosine residue at the N-terminus.
AOD 9604 peptide can
- Reduce the body fat
- Trigger the release of fat from fat cells
- Stimulate lipolysis (triglyceride breakdown)
- Inhibit lipogenesis
- Improve the metabolic profiles
- Help with cartilage and bone repair
AOD 9604 may be used to enhance the performance of drugs and is being prohibited by the World Anti-doping Agency (WADA). It has gained accessibility through various online platforms. (Cox et al. 2014)
Structure Of AOD 9604 Peptide
You can legally buy AOD 9604 peptide from NuScience Peptide here.
Let’s take a look at the AOD 9604 benefits that it can provide for us.
Part 2. AOD 9604 Benefits and Advantages
In this portion, the benefits of the AOD 9604 peptide from different studies will be discussed. Let’s explore these advantages one by one in detail.
1. Management of Obesity
Obesity poses a significant risk of mortality. It contributes to conditions like
- Type 2 diabetes
- Insulin resistance
- Cardiovascular diseases.
Effective anti-obesity medications become crucial, especially for individuals with a body mass exceeding 30 kg/m².
AOD 9604 peptide influences biological mechanisms to regulate appetite and nutrient absorption. This peptide exhibits promise in addressing obesity-related complications.
It also aligns with the need for therapies that not only aid weight loss but also reduce cardiovascular risks. (Khan et al. 2012)
Obesity Patient Numbers Globally
2. Skeletal Effects on the Aged Rat
The research indicates that AOD 9604 reduces the adverse impacts of OVX on bone properties.
AOD treatment resulted in
- Higher bone mineral density (BMD)
- Higher Bone mineral content (BMC)
- Predominant effect on cortical Bone
- Positive influence on trabecular Bone
The study suggests that AOD 9604 operates similarly to GH, with a lower dose potential effectiveness.
It also highlights the importance of optimal dosage in gathering skeletal benefits.
3. Increase in Lipolytic Activity
In an experiment with obese Zucker rats, an oral dose of AOD 9604 at 500 µg/kg body weight was administered daily for 19 days.
- The results revealed a remarkable reduction in body weight gain by over 50% compared to the control group.
- The fatty tissues of the AOD 9604 treated rats exhibited an increase in lipolytic activity.
- Chronic administration of AOD 9604 did not adversely affect the insulin sensitivity of the animals.
These findings indicate that AOD 9604 holds promise as a safe and possible option for managing obesity. It also emphasizes its positive impact on lipolysis without compromising insulin sensitivity. (Ng, F.M et al. 2001)
This information was all about the benefits of AOD 9604. Now, let’s discuss its drawbacks.
Part 3. AOD 9604 Side Effects
AOD 9604, recognized by the FDA for its weight loss benefits, is generally considered safe, with least potential risks.
However, like any new substance, there are potential side effects, typically mild to moderate. These may include
- Headaches
- Indigestion
- Swelling
- Fatigue
AOD 9604 is safe for short-term use, with some side effects which are generally not severe. Caution is advised, particularly for long-term use.
It’s necessary to consult a doctor before starting treatment to check the similarity with existing medications and overall safety.
You can legally buy AOD 9604 peptide from NuScience Peptide here.
As we move forward, let’s turn our attention to the dosages of AOD 9604 peptide.
Part 4. AOD 9604 Dosage Explained
Appropriate dosage for AOD 9604 involves considering individual needs and goals. Consultation with a healthcare professional is encouraged, especially if one is using other medications.
There is no universal dosage guideline for AOD 9604.
For research purposes, starting with a low dosage, around 300 mcg per day, is suggested. Prior consultation with a physician is crucial to assess potential interactions with other substances.
It is advisable to store AOD 9604 in a cool location, such as a refrigerator, to maintain its stability.
Remember, on NuScience Peptide, the product is for research purposes only and is available in a 5mg form.
Next, we’ll explore the platform where you can conveniently and securely purchase this peptide.
Part 5. Best Place To Buy AOD 9604 Peptide Online?
At NuScience Peptide, we take pride in providing researchers like you with a reliable platform to access the AOD 9604 peptide.
With over 20 years of experience in the research product field, our platform is designed to offer a seamless and user-friendly experience.
Why choose NuScience Peptide?
NuScience Peptide is an online store that provides you with the following advantages over other sites.
1. Same Day Shipping
Experience unique comfort with our same-day shipping service. Place your order before 12:00 pm EST, and we will ensure fast delivery of all in-stock items.
2. Dedicated Service
Our dedicated team stands ready to assist you. From addressing inquiries to fulfilling customer service requests, we prioritize your satisfaction.
3. Free Shipping
Boost your shopping experience with our offer of free shipping on all orders totaling $125 or more.
4. Purist Quality
Each item from NuScience Peptide undergoes careful lab testing, ensuring the highest level of purity. We take pride in delivering quality you can rely on for your research needs.
AOD 9604 Peptide from NuScience Peptides
You can legally buy AOD 9604 peptide from NuScience Peptide here.
Conclusion
AOD 9604 peptide emerges as a promising drug in the domain of obesity management and metabolic improvement. As the peptide exhibits an increase in lipolytic activity, it’s crucial to note its safe profile with minimal side effects.
NuScience Peptide stands as your trustworthy source for AOD 9604 peptide. It offers a seamless experience supported by over 20 years of industry expertise.
Upgrade your research journey with NuScience Peptide – where quality meets comfort.
You can legally buy AOD 9604 peptide from NuScience Peptide here.
DISCLAIMER
The information provided in this article is for educational and informational purposes only. It does not constitute medical or professional advice. The content is based on research findings and publications.
Readers are encouraged to consult with healthcare professionals before using the AOD 9604 peptide. The article does not promote the misuse of AOD 9604 or any related products for non-research purposes.
NuScience Peptide is not liable for any consequences arising from the performance of the information provided herein. Users are responsible for their actions and decisions.
References
Cox, H. D., Smeal, S. J., Hughes, C. M., Cox, J. E., & Eichner, D. (2014). Detection and in vitro metabolism of AOD9604. Drug Testing and Analysis, 7(1), 31–38. https://doi.org/10.1002/dta.1715
Fawcett, E. E. (2004, January 1). The skeletal effects of a growth hormone-derived peptide (AOD9604) in the aged rat model of postmenopausal osteoporosis. TSpace Repository. https://tspace.library.utoronto.ca/handle/1807/112838
Khan, A., Raza, S., Khan, Y., Aksoy, T., Khan, M., Weinberger, Y., & Goldman, J. (2012). Current updates in the medical management of obesity. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 6(2), 117–128. https://doi.org/10.2174/187221412800604644
Ng, F. M., Sun, J., Sharma, L., Libinaka, R., Jiang, W. J., & Gianello, R. (2001). Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Hormone Research, 53(6), 274–278. https://doi.org/10.1159/000053183